APC and colorectal carcinoma: In 2020, a study conducted by Mondaca, Walch and colleagues assessed the impact of APC mutation site on the survival of metastatic CRC patients with MSS and found that C-terminal mutations were correlated with a shorter overall survival and progression-free survival [28].